Clinical Impact of Sarcopenia Screening on Long-Term Mortality in Patients Undergoing Coronary Bypass Grafting
- PMID: 39513369
- PMCID: PMC11634471
- DOI: 10.1002/jcsm.13645
Clinical Impact of Sarcopenia Screening on Long-Term Mortality in Patients Undergoing Coronary Bypass Grafting
Abstract
Background: Sarcopenia is an aging-related condition characterized by loss of skeletal muscle mass and is an indicator of subclinical atherosclerosis. The relationship between reduced muscle mass and long-term clinical outcomes in patients with advanced coronary artery disease who have undergone coronary artery bypass grafting (CABG) is not fully understood. This study is sought to evaluate the prognostic implications of sarcopenia screening in patients undergoing CABG.
Methods: A total of 2810 patients who underwent CABG were analysed and classified according to presence of reduced muscle mass. The skeletal muscle index (SMI) was calculated as L3 muscle area (cm2)/height (m)2 on computed tomography. Reduced SMI was defined as SMI ≤ 45 cm2/m2 in male and ≤ 38 cm2/m2 in female. The primary outcome was all-cause mortality, and survival analysis was performed using the Kaplan-Meier method and compared with the log-rank test.
Results: The median follow-up was 8.7 years, and 924 patients (32.9%) had reduced SMI. Patients with reduced SMI were older (67.7 ± 8.8 vs. 62.2 ± 9.8 years; p < 0.001) and less frequently male (69.8% vs. 81.1%; p < 0.001). SMI was significantly associated with risk of death on a restricted cubic spline curve (HR = 1.04 per-1 decrease; 95% CI 1.03-1.05; p < 0.001). Patients with reduced SMI had a higher incidence of long-term mortality than those with preserved SMI (survival rate 41.4% vs. 62.8%; HRadj = 1.18, 95% CI 1.03-1.36, p = 0.020). Subgroup analysis showed that the prognostic implication of reduced SMI on long-term survival was more evident in male (HRadj = 2.01, 95% CI 1.72-2.35) than female (HRadj = 1.28, 95% CI 0.98-1.68) (interaction p = 0.006).
Conclusions: Reduced muscle mass, defined by SMI on computed tomography, was associated with long-term mortality after CABG. These results provide contemporary data to allow the evaluation of physical frailty in patients with advanced coronary artery disease before surgery.
Trial registration: Long-Term Outcomes and Prognostic Factors in Patients Undergoing CABG or PCI: NCT03870815.
Keywords: coronary artery bypass grafting; coronary artery disease; frailty; prognosis; sarcopenia.
© 2024 The Author(s). Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Clinical impact of visceral adiposity on long-term mortality in patients undergoing coronary artery bypass grafting.Rev Esp Cardiol (Engl Ed). 2025 May;78(5):437-446. doi: 10.1016/j.rec.2024.09.002. Epub 2024 Sep 28. Rev Esp Cardiol (Engl Ed). 2025. PMID: 39349122 English, Spanish.
-
The Impact of Cerebral Atherosclerosis According to Location on Prognosis after Coronary Artery Bypass Grafting.Cerebrovasc Dis. 2018;46(5-6):200-209. doi: 10.1159/000494502. Epub 2018 Nov 8. Cerebrovasc Dis. 2018. PMID: 30408800
-
Thoracic sarcopenia predicts clinical outcomes in patients undergoing coronary artery bypass grafting: A 6-year cohort study.Asian J Surg. 2023 Jan;46(1):291-298. doi: 10.1016/j.asjsur.2022.03.096. Epub 2022 Apr 9. Asian J Surg. 2023. PMID: 35414459
-
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071. J Am Coll Cardiol. 2018. PMID: 30025574
-
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.Am Heart J. 2017 Aug;190:54-63. doi: 10.1016/j.ahj.2017.05.005. Epub 2017 May 18. Am Heart J. 2017. PMID: 28760214 Review.
Cited by
-
Mitochondrial Dysfunction Contributes to Sustained Muscle Loss After Cardiac Surgery: A Prospective Observational Study.J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70051. doi: 10.1002/jcsm.70051. J Cachexia Sarcopenia Muscle. 2025. PMID: 40842041 Free PMC article.
-
Biomarkers of aging: from molecules and surrogates to physiology and function.Physiol Rev. 2025 Jul 1;105(3):1609-1694. doi: 10.1152/physrev.00045.2024. Epub 2025 Mar 20. Physiol Rev. 2025. PMID: 40111763 Free PMC article. Review.
-
AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma.Sci Rep. 2025 Jul 21;15(1):26455. doi: 10.1038/s41598-025-11560-3. Sci Rep. 2025. PMID: 40691492 Free PMC article.
References
-
- Head S. J., Kieser T. M., Falk V., Huysmans H. A., and Kappetein A. P., “Coronary Artery Bypass Grafting: Part 1—The Evolution Over the First 50 Years,” European Heart Journal 34 (2013): 2862–2872. - PubMed
-
- Lawton J. S., Tamis‐Holland J. E., Bangalore S., et al., “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” Journal of the American College of Cardiology 79 (2022): e21–e129. - PubMed
-
- McNeely C., Markwell S., and Vassileva C., “Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population,” The Annals of Thoracic Surgery 102 (2016): 132–138. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous